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Abstract: Lymphoma is one of the most common malignancies in domestic cats. The lymphomagenic
potential of Felis catus gammaherpesvirus 1 (FcaGHV1), a common infection in domestic cats,
is unknown. In other species, including humans, cellular transformation by gammaherpesviruses
is typically mediated by viral genes expressed during latency. We analysed tumour RNA, from
diffuse large B-cell lymphomas (DLBCL) appearing in cats coinfected with FcaGHV1 and feline
immunodeficiency virus (FIV) (n = 10), by high throughput transcriptome sequencing and reverse
transcription PCR. A limited repertoire of FcaGHV transcripts was identified in five tumors, including
homologs of oncogenic latency-associated transcripts, latency-associated nuclear antigen (LANA,
ORF73) and vFLIP (F7), lytic genes (ORF50, ORF6, ORF59, F10), and an ORF unique to FcaGHV1,
F20. In situ hybridization of FIV-associated DLBCLs (n = 9), post-transplant lymphomas (n = 6) and
high-grade B and T-cell intestinal lymphomas (n = 8) identified a single case in which FcaGHV1
nucleic acid was detectable. These results demonstrate that FcaGHV1 transcripts can be detected in
some FIV-associated lymphomas, but at low copy number, precluding assessment of a potential role
for FcaGHV1 in lymphomagenesis. Future investigation of the FcaGHV1 transcriptome in clinical
samples might employ viral enrichment and greater sequencing depth to enhance the retrieval of
viral reads. Our results suggest prioritization of a subset of intestinal T-cell tumors, large granular
lymphocyte lymphoma, for study.
Keywords: gammaherpesvirus; immunodeficiency; virus; domestic cat; felid; lymphomagenesis;
oncogenic; transcriptome; lymphoma; cancer; B-cell; T-cell
Felis catus gammaherpesvirus 1 (FcaGHV1; proposed species Felid gammaherpesvirus 1) was first
reported in domestic cats in 2014 [1]. The targeted search that discovered FcaGHV1 was predicated
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on the hypothesis that a gammaherpesvirus would be causal in feline immunodeficiency virus
(FIV)-associated lymphoma, just as the Epstein-Barr virus (EBV) and Kaposi’s sarcoma-associated
herpesvirus (KSHV), are causal in 30–95% of HIV-associated lymphomas in humans [2,3].
Understanding the pathogenic potential of FcaGHV1 in cats is relevant to an expanding companion
animal health market and may provide insights into human disease.
Herpesviruses alternate between lytic and latent replication cycles. During viral latency, the genome
is maintained as an episome and a limited repertoire of genes is transcribed. Latency-associated transcripts
collectively confer a survival advantage to maintain a viral reservoir through diverse mechanisms
that promote cell growth, inhibit apoptosis and downregulate immunological targets [4]. These same
genes promote cell transformation and gammaherpesvirus-associated cancers, including lymphoma.
Oncogenesis occurs in a minority of gammaherpesvirus infections, often many years after the primary
infection. Predisposing factors, such as immunodeficiency, are identified in some, but not all cases [5].
Although rare, gammaherpesvirus-associated cancers are frequently fatal. A full understanding of the
mechanisms by which specific gammaherpesviruses transform cells is evolving, but the presence of
transcriptionally active virus within cancer cells is a prerequisite to establish a direct causal relationship.
In addition to established repertoires of latency-associated transcripts, an increasing number of lytic genes
are implicated in tumorigenesis [6–9]. The role of gammaherpesviruses in oncogenesis can be informed
from the spectrum of genes transcribed in cancer cells.
FcaGHV1 infection has been reported in cats from Australia, USA, UK, central Europe, Japan,
Singapore and Brazil, with 9.6% to 23.6% testing positive for FcaGHV1 on whole blood quantitative
real-time PCR (qPCR) [1,10–14]. One study showed that anti-FcaGHV1 antibodies identified persistent
infection in 35% of cats, and the true infection prevalence may be higher [15]. So, while FcaGHV1
infection is common, any disease that it might cause is expected to be rare. Defining the pathogenicity
of FcaGHV1 will rely on accumulating evidence from multiple lines of investigation.
We investigated the transcriptome of FIV-associated lymphomas with complimentary techniques,
deep sequencing and reverse transcriptase (RT)-PCR, to identify FcaGHV1 transcription. In situ
hybridization (ISH) was used to identify the cellular location of FcaGHV1 nucleic acid in FIV-associated
lymphomas, post-transplant lymphomas and high-grade B and T-cell gastrointestinal lymphomas.
Transcriptome analysis was performed on large cell, high-grade B-cell lymphomas consistent
with diffuse large B cell lymphoma (DLBCL), arising in cats infected with FIV [16]. The antemortem
diagnosis of FIV was based on a positive serology result in a cat that had not been vaccinated against
FIV [17]. Necropsy samples were stored at −80 ◦C for transcriptome analysis. Sample collection was
approved by the University of Sydney Animal Ethics Committee N00/7-2013/3/6029 and 2014/626.
Cases were included if they tested positive for FcaGHV1 DNA in whole blood by qPCR or tumour
tissue by conventional PCR (cPCR) [1,18] (n = 10). Cases were excluded if they tested seropositive
for the directly oncogenic gammaretrovirus feline leukemia virus (FeLV) [19]. FIV infection status
was confirmed by PCR of tumour-derived DNA for FIV gag, as described previously [18]. Total
RNA was extracted from frozen tumour, as described previously [20]. In the first round of NGS,
libraries were prepared for cases 1, 2 and 8 using a TruSeq RNA library preparation kit (Illumina,
San Diego, CA, USA). Cytoplasmic ribosomal RNA was depleted using a Ribo-Zero Gold rRNA
removal kit (human/mouse/rat) (Illumina, San Diego, CA, USA). The 75 bp paired-end libraries
were then run on an Illumina NextSeq platform (San Diego, CA, USA). Library preparation for
a second round of RNA sequencing was performed for samples 1 to 10 (Table 1) using identical
preparation except that ribosomal RNA was removed using a Ribo-Zero Gold rRNA removal kit
(epidemiology) (Illumina). RNA sequencing of 100 bp paired-end libraries was performed on an
Illumina HiSeq 2500 platform. To estimate the abundance of FIV and FcaGHV1, the reads from
each library were mapped to the corresponding genomes using Bowtie2 software [21]. The mapping
results were subsequently visualized and manually examined using the Interactive Genomic Viewer
(http://software.broadinstitute.org). To confirm the mapping results, we also performed blastn [22]
and diamond blast [23] analyses of reads, against the comprehensive non-redundant nucleotide (nt)
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and protein (nr) databases, respectively. The reads identified as FcaGHV1 transcripts were consistent
with those discovered by the mapping approach. For comparison, the reads were also mapped to
beta-glucuronidase (GUSB) which is stably expressed in cats [24]. Viral reads mapping to FcaGHV1
lytic gene homologs ORF50, ORF6, ORF59, F10 were recovered. ORF50 triggers reactivation from
latency and inhibits apoptosis [25], F10, a KSHV K3 homolog, and downregulates MHC-I, whereas
ORF59 and ORF6 encode a polymerase and a DNA binding protein, respectively. Two reads mapped
to an ORF unique to FcaGHV1, F20, of unknown function [26].
Table 1. Summary of transcriptome analyses of feline immunodeficiency virus associated lymphoma
from FcaGHV1 infected cats.
Cases
NextSeq
FcaGHV1 Reads
HiSeq Number of Reads RT-PCR
Total GUSB FIV FcaGHV1 FcaGHV1ORF50
FcaGHV1
ORF73
FcaGHV1
F7
1 Neg 294,779,800 4149 1023 0 Neg Neg Neg
2 4 (ORF 50) 338,384,008 8070 2959 0 POS POS POS
3 - 288,176,064 4152 48,270 0 Neg Neg Neg
4 - 317,655,184 6526 32 0 POS Neg POS
5 - 300,408,704 1608 4090 0 Neg Neg Neg
6 1 - 321,297,408 12,866 1636
2
(ORF59) Neg Neg POS
7 - 337,067,856 21,636 100 0 Neg Neg Neg
8 Neg 328,445,328 5103 2207 0 POS Neg POS
9 - 313,060,728 1410 141
2 (F10)
2 (F20)
2 (ORF6)
Neg Neg Neg
10 - 239,825,576 1973 11 0 Neg Neg Neg
Cases are large cell, high-grade B-cell lymphomas from feline immunodeficiency viruses (FIV) and Felis catus
gammahepresvirus 1 (FcaGHV1) infected cats. Numbers represent reads obtained from high throughput sequencing
of tumor RNA (NextSeq and/or HiSeq). Total, beta-glucuronidase (GUSB), and viral reads are presented. For
FcaGHV1, the region to which reads map is shown in brackets. Results of RT-PCR of tumor RNA for FcaGHV1
ORF50, ORF 73 and F7 are indicated as positive (POS) or negative (NEG). The identify of amplicons obtained by
RT-PCR was confirmed by sequencing. 1 A novel hepadnavirus discovered in this case is reported elsewhere [20].
RT-PCR of tumor RNA was performed as an alternative approach to identify FcaGHV1 transcripts.
Total tumor RNA was prepared as before. RNA quality and purity, examined using an Agilent
Bioanalyzer 2100 (Agilent Technologies, Melbourne, Australia), demonstrated RNA integrity numbers
>8. Primers were designed to amplify FcaGHV1 ORF50, which had been identified on NextSeq, as well
as FcaGHV1 ORF73 and F7, predicted to encode homologues of latency-associated nuclear antigen
(LANA) and vFLIP, respectively, both of which are lymphomagenic in transgenic mice (Table 2) [26,27].
One-step RT-PCR was used to detect viral transcripts in low abundance (One-step Ahead RT-PCR
kit; Qiagen, Hilden, Germany) using up to 1 µg of RNA as the template. Reverse transcription was
carried out at 52 ◦C for 10 minutes. This was followed by PCR activation at 95 ◦C for 5 min, a 35 cycles
of denaturation at 95 ◦C for 1 min, annealing at 56–57 ◦C for 15 s, extension at 72 ◦C for 10 s, and a
final extension at 72 ◦C for 5 min. The identity of PCR products migrating at the expected size on gel
electrophoresis was confirmed by Sanger sequencing (Macrogen sequencing, Seoul, Korea).
Table 2. Oligonucleotides used to detect Felis catus gammaherpesvirus 1 transcripts in feline
immunodeficiency virus -associated lymphoma by RT-PCR.
Oligonucleotide Sequence Size (bp) Tm (◦C)
ORF50-F1 5′-CCCAGGGCTTTTTGTGTGGA-3′
301 57ORF50-R1 5′-GGGCTTGACTCATAAGGGCA-3′
ORF73-F2 5′-CAACTGGGCATTGGCATAC-3′
110 57ORF73-R2 5′-CCTTAGTTCACCCAACTTGTGC-3′
F7-F 5′-ACTCTGTGTCTGGGAATGTGAC-3′
153 56F7-R 5′-TGGCTTGTGTATATGGCCAGC-3′
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For ISH, formalin-fixed paraffin-embedded (FFPE) tissues from 9 of the FIV-associated lymphomas
were investigated. In addition, archived diagnostic samples from post-renal transplant large B-cell
lymphomas (n = 6) and high-grade B- and T-cell gastrointestinal lymphomas (n = 8) were retrieved.
The causal role for gammaherpesviruses in lymphomas arising in human transplant recipients provided
the rationale for investigating feline post-transplant lymphomas [28]. High grade gastrointestinal
lymphomas were included because the global control of FeLV has seen these tumors become a dominant
subtype and their cause is unknown [29,30]. FFPE tumour-derived DNA from post-transplant and
gastrointestinal tumours was tested for FcaGHV1 by cPCR prior to ISH, as described previously [18].
An anti-sense ISH probe for FcaGHV1 ORF50 was custom-designed (Advanced Cell Diagnostics,
Newark, CA, USA). This probe can detect both DNA and RNA, where the target is a double-stranded
DNA virus, such as a herpesvirus. Four-micron tissue sections were prepared on charged glass slides
(Superfrost Plus, Thermoscientific, Waltham, MA, USA). Sample preparation and pretreatment for the
RNAscope 2.5 Assay were carried out according to the manufacturer’s instructions (Advanced Cell
Diagnostics, Newark, CA, USA). Hybridized probe was identified with RNAscope®2.5 HD Detection
Reagent-Red. Samples were tested with an FcaGHV1 ORF50 probe, and a probe for bacterial gene
DapB served as a negative control.
Transcriptomic analyses detected a limited repertoire of FcaGHV1 transcripts (100% match) in
5 of 10 FIV-associated lymphomas (Table 1). FcaGHV1 transcripts included homologs of KSHV
latency-associated transcripts LANA and vFLIP, which induce B-cell lymphomas in mice [31,32].
LANA, KSHVs major latency protein, contributes to the maintenance of episomal DNA in proliferating
cells, by tethering the episome to the host genome. The mechanisms by which LANA promotes
KSHV-associated lymphomagenesis include the inhibition of tumor suppressor genes p53 and Rb,
and stabilization of protooncogene-encoded MYC [27]. vFLIP has anti-apoptotic effects mediated by
preventing the activation of the protease, caspase 8 [27]. Although only 2 to 4 reads per FcaGHV1
transcript were detected, we believe that the transcripts can be considered genuine as they were
identified using multiple approaches. In addition, we initially discovered a novel domestic cat
hepadnavirus from 8 transcripts in case 6, which was later confirmed by PCR in a larger number of
animals [20].
Metatranscriptomics of clinical samples can reveal the pattern of viral gene expression within
cancer cells, without bias introduced by viral enrichment. Nonetheless, the direct investigation of
clinical samples presents several challenges. Firstly, host non-rRNA reads are expected to dwarf those
of a latent virus. The very low abundance of transcripts retrieved, suggests that the sensitivity of
these methods is close to the lower limit of detection for FcaGHV1 transcripts in clinical specimens.
Secondly, tumors are heterogeneous containing inflammation and necrosis alongside cancer cells,
and cells undergoing lytic as well as latent virus replication. This can contribute to inconsistency in
results as a consequence of sampling different regions of the same tumor. Future investigations of the
FcaGHV1 transcription profile in clinical specimens, invoking deeper sequencing, library baiting, and
absolute quantitation are expected to yield valuable information.
One post-transplant lymphoma and one gastrointestinal lymphoma tested positive for FcaGHV1
by cPCR. From 23 tumors tested by ISH, a single gastrointestinal lymphoma yielded a positive result.
This tumor, a high-grade, T-cell lymphoma, subtyped as a large granular lymphocyte lymphoma, was
the sample that tested positive for FcaGHV1 by cPCR. A positive intranuclear signal was identified
in >90% of neoplastic lymphocytes. This result has been repeatable in two laboratories (PP and JB)
(Figure 1). An identical pattern of staining was obtained when this tumor was tested by ISH for
FcaGHV1 ORF73 and with a combined F7, F10, F20 probe. In contrast, the other 22 lymphomas were
consistently negative for FcaGHV1 on ISH, and the unrelated control probe gave a negative result
in all 23 samples with ISH. In the single ISH positive tumor, the consistent intranuclear signal and
the absence of a cytoplasmic signal with any FcaGHV1 ISH probe, supports that episomal FcaGHV1
DNA is maintained in the majority of neoplastic lymphocytes in this intestinal T-cell, large granular
lymphocyte lymphoma. Further studies are required to understand whether the continued presence of
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the virus is required to maintain tumor phenotype, as it is with other GHV-associated cancers [33].
Of note here, the published FcaGHV1 genome sequence was obtained from a lymph node, selected for
its high FcaCaGHV1 load of 48 FcaGHV1 genomes per cell, from a case of high-grade, T-cell intestinal
lymphoma [26].
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In summary, FcaGHV1 transcripts can be detected in some FIV-associated lymphomas, but at
low copy number which precludes assessment of a potential role for FcaGHV1 in lymphomagenesis.
Our results identify a subset of intestinal T-cell tumors, large granular lymphocyte lymphoma that can
be targeted in future investigations of the pathogenic potential of FcaGHV1.
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